Nesa Medtech Receives FDA Clearance for Its Fibroid Mapping Reviewer Application

Nesa Medtech

Nesa Medtech advises their novel SaMD technology generates a 3D model of uterus to facilitate treatment in patients with symptomatic uterine fibroids

← Previous
Next →
  • Medical Specialists Subscribe
  • Industry Subscribe
  • Privacy Statement
    • Cookie Policy
  • Contact
  • Medical Specialists Subscribe
  • Industry Subscribe
  • Privacy Statement
    • Cookie Policy
  • Contact
  • ADVERTISE
  • ADVERTISE

© 2026 All rights Reserved. Medical Device News Magazine, a Division of PTM Healthcare Marketing, Inc.